DrugPatentWatch serves companies across the drug development-delivery sector. A common request among drug manufacturers, payers, and suppliers alike is anticipation […]
Customer Success: Will a generic version of a drug launch? And when? Read Post »
Changes in drug markets can create growth opportunities for API manufacturers and CDMOs alike. Whether change comes from generic entry,
Customer Success: API and CDMO Business Development Read Post »
DrugPatentWatch has deep resources to support patent prosecution and patent litigation, but it is also used by law firms for
The launch of a new product can be a daunting task. The main reason this happens is that no matter
Mistakes to Be Avoided When Preparing a Drug Launch Read Post »
This article was originally published by Garth Boehm, Lixin Yao, Liang Hana, and Qiang Zheng in Acta Pharmaceutica Sinica under
Development of the generic drug industry in the US after the Hatch-Waxman Act of 1984 Read Post »
DrugPatentWatch can help identify generic entrants at the earliest stages Many clients come to DrugPatentWatch seeking to identify generic entrants
Customer Success: How do we identify generic entrants before they get FDA approval? Read Post »
The latest Swiss Biotech annual report focuses on the theme of shaping change. Change is a theme DrugPatentWatch is very
DrugPatentWatch Headlines Swissbiotech Annual Report Read Post »
This article was originally published by Christopher M. Holman* in Intellectual Property Watch under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International
Why Follow-On Pharmaceutical Innovations Should Be Eligible For Patent Protection Read Post »
This paper was originally published by Maya Tannoury and Zouhair Attieh in Current Therapeutic Research under a creative commons license.
The Influence of Emerging Markets on the Pharmaceutical Industry Read Post »
Get fresh news and insights, drug patent expirations & more…
